Clinical Trials Logo
  1. Home
  2. Basal Cell Carcinoma
  3. NCT05046262
  4. Details
NCT05046262 Clinical Trial

Calcium Electroporation for Basal Cell Carcinomas - Proof of Concept Study

Basal Cell Carcinoma Clinical Trial

Official title:
Calcium Electroporation for Basal Cell Carcinomas - Proof of Concept Study

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT05046262
Other study ID # EudraCT 2019-002730-36
Secondary ID
Status Recruiting
Phase Phase 3
First received
Last updated
Start date January 8, 2020
Est. completion date February 22, 2022

Study information
Verified date September 2021
Source Bispebjerg Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

25 patients with primary low-risk basal cell carcinoma treated with calcium electroporation

Description:

25 patients with primary low-risk basal cell carcinoma treated with calcium electroporation, if partial or no response after 3 months the treatment was repeated. Follow-up 3 and 12 months after last treatment.

Recruitment information / eligibility
Status Recruiting
Enrollment 25
Est. completion date February 22, 2022
Est. primary completion date February 22, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Primary low risk basal cell carcinoma less than 3 cm in diameter - Exclusion Criteria: Immunosuppression or organ transplant recipients Pregnancy or breastfeeding Allergy to local anesthetics

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Calcium chloride
Calcium electroporation

Locations
Country Name City State
Denmark Department of Dermatology, Bispebjerg Hospital Copenhagen

Sponsors (2)
Lead Sponsor Collaborator
Bispebjerg Hospital Mirai Medical, Ireland

Country where clinical trial is conducted

Denmark, 

Outcome
Type Measure Description Time frame Safety issue
Primary complete response 3 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04552990 - Use of Jet-injection in Photodynamic Therapy for Basal Cell Carcinoma Phase 2
Completed NCT04229277 - Fast Track Diagnosis of Skin Cancer by Advanced Imaging N/A
Completed NCT05608902 - Structural Description of Skin Biopsies With Dynamic Full-field Optical Coherence Tomography on Suspected Basal Cell Carcinoma Lesions, a Pilot Study (DOCTOBA)
Completed NCT05077033 - Intratumoral phIL12 GET Phase 1
Active, not recruiting NCT04928222 - Placebo Microneedles in Healthy Volunteers (Part I) and Efficacy/Safety of Doxorubicin Microneedles in Basal Cell Cancer Subjects (Part II) Phase 1/Phase 2
Recruiting NCT04929535 - Hydrogen Peroxide Trial to Investigate the Efficacy of 30%H2O2 as a Topical Application Before Definitive Treatment Phase 2
Completed NCT02662244 - Long-pulsed 1064 nm Nd:YAG Laser Treatment of Basal Cell Carcinoma N/A
Completed NCT00959647 - A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study Phase 2
Completed NCT00793169 - Serum Concentration of Lidocaine After Local Injection During Mohs Micrographic Surgery
Completed NCT00586040 - Photochemical Tissue Bonding Phase 2
Completed NCT00473343 - Metvix PDT in Participant With "High Risk" Basal Cell Carcinoma Phase 3
Active, not recruiting NCT06024629 - cOCT Versus LC-OCT for Diagnosing Basal Cell Carcinoma: a Diagnostic Cohort Study
Not yet recruiting NCT05324202 - New Imaging Procedures and Therapeutic Approach in Basal Cell Carcinoma Management N/A
Withdrawn NCT04099446 - A Non-Interventional Pilot Study to Explore the Skin Microbes in Skin Cancer
Completed NCT02902822 - Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo N/A
Completed NCT01208831 - An East Asian Study of LDE225 Phase 1
Completed NCT01201915 - A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449) in Operable Basal Cell Carcinoma Phase 2
Completed NCT01260987 - Fractional CO2 Laser Assisted Photodynamic Therapy Phase 2/Phase 3
Completed NCT01014819 - A Clinical Trial of Dermacorder for Detecting Malignant Skin Lesions N/A
Completed NCT00472043 - PDT With Metvix 160 mg/g Cream Versus PDT With Placebo Cream in Patients With Primary Nodular Basal Call Carcinoma Phase 3